Embolotherapy Market 2026–2030: Forecast, Innovation, and Competitive Trends

Uncover key drivers, emerging technologies, and competitive movements shaping the embolotherapy market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Embolotherapy Market between 2026 and 2030?

The embolotherapy market has experienced substantial growth in recent years. It is forecast to expand from $4.84 billion in 2025 to $5.27 billion in 2026, at a compound annual growth rate (CAGR) of 8.9%. This past growth can be attributed to the rise of interventional radiology practices, the increasing incidence of cancer, improvements in catheter technologies, a decrease in surgical complication rates, and the expansion of hospital infrastructure.

The embolotherapy market is projected to experience substantial expansion in the coming years. Its valuation is set to reach $7.33 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.6%. This anticipated growth throughout the forecast period stems from factors such as an increasing oncology patient population, a heightened need for organ-preserving therapies, advancements in liquid embolic agents, the proliferation of ambulatory surgical centers, and enhancements in imaging and navigation systems. Key trends identified for the forecast timeframe encompass the growing acceptance of minimally invasive procedures, greater application of image-guided interventional therapies, a surge in demand for targeted cancer treatments, continuous technological progress in embolic materials, and an expansion of interventional radiology services.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21181&type=smp

Which Drivers Are Expected To Impact The Embolotherapy Market During The Forecast Period?

The increasing inclination towards minimally invasive treatments is anticipated to drive expansion in the embolotherapy market in the future. These procedures are defined as cosmetic interventions that demand minimal to no surgical involvement, generally offering reduced recovery periods and diminished risks. This growing preference for such procedures stems from benefits like quicker healing, less discomfort, smaller scars, decreased chances of complications, and ongoing technological progress. Embolotherapy complements minimally invasive techniques by precisely obstructing blood flow to specific vessels, thereby lessening bleeding, addressing tumors, and handling vascular irregularities with enhanced accuracy and fewer adverse effects. An example is provided by the American Society of Plastic Surgeons, a US-based non-profit organization, stating that in September 2023, cosmetic minimally invasive procedures saw a 7% increase in 2023, reaching 25,442,640, compared to 23,672,269 in 2022. Consequently, the increased favoritism for minimally invasive methods is fueling the expansion of the embolotherapy market.

How Is The Embolotherapy Market Divided Into Segments?

The embolotherapy market covered in this report is segmented –

1) By Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices

2) By Application: Oncology, Peripheral Vascular Diseases, Urology And Nephrology, Neurology, Gastrointestinal (GIT) Disorders

3) By Procedure: Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE) Or Selective Internal Radiation Therapy (SIRT), Transarterial Chemoembolization (TACE)

4) By End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users

Subsegments:

1) By Embolization Coil: Bare Coils, Coated Coils, Micro Coils

2) By Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol (PVA) Particles

3) By Detachable Balloons: Single-Use Balloons, Multi-Use Balloons

4) By Embolic Plug Systems: Plug Kits, Distal Occlusion Systems

5) By Support Devices: Guidewires, Catheters, Sheath Introducers

Which Trends Are Influencing The Development Of The Embolotherapy Market?

Major companies active in the embolotherapy market are prioritizing the development of innovative products, such as absorbable embolic systems, to enhance patient outcomes and broaden available treatment options. Absorbable embolic systems refer to bioresorbable materials utilized in embolization procedures to block blood flow to targeted tissues, including tumors or aneurysms, while progressively degrading within the body over time. For instance, in January 2025, Instylla Inc., a US-based medical equipment manufacturing company, secured U.S. Food and Drug Administration (FDA) 510(k) clearance for its Tembo embolic system, a bioresorbable embolization agent crafted from irregularly shaped, dry-gelatin particles measuring between 85 and 255 µm. The system is engineered to embolize hypervascular tumors and to occlude blood vessels within the peripheral vasculature. According to Instylla, Tembo offers advantages such as ease of preparation, high visibility, and the ability to densely pack treated vessels, potentially improving upon existing permanent embolic solutions.

Which Key Market Players Are Investing In Expansion And Innovation Within The Embolotherapy Market?

Major companies operating in the embolotherapy market are Boston Scientific Corporation, Terumo Medical Corporation, Medtronic PLC, Johnson And Johnson, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Meril Life Sciences Pvt. Ltd., Guerbet, Cardiva, Rapid Medical, Emboline Inc, Microport Scientific, Embolx Inc, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE (SHENZHEN) CO. LTD, Varian Medical Systems Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Embolotherapy Market?

North America was the largest region in the embolotherapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the embolotherapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Embolotherapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21181&type=smp

Browse Through More Reports Similar to the Global Embolotherapy Market 2026, By The Business Research Company

Transcatheter Embolization And Occlusion Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/transcatheter-embolization-and-occlusion-devices-global-market-report

Pulmonary Embolism Market Report 2026

https://www.thebusinessresearchcompany.com/report/pulmonary-embolism-global-market-report

Embolization Coils Market Report 2026

https://www.thebusinessresearchcompany.com/report/embolization-coils-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795